Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart

Xi Ping Huang, Ana Ludke, Sanjiv Dhingra, Jian Guo, Zhuo Sun, Li Zhang, Richard D. Weisel, Ren Ke Li

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds